Oncolytic Vaccinia Virus Combination Cancer Therapy

Abstract

Embodiments of the invention are directed methods that include a thymidine kinase deficient vaccinia virus. The methods include evaluating a tumor for reperfusion after treatment with vaccinia virus and administering an anti-angiogenic agent if reperfusion is detected.


Claims
Download PDF
Document Preview
Document History
  • Publication: Jun 10, 2014
  • Application: Sep 14, 2010
    US US 201013395929 A
  • Priority: Sep 14, 2010
    US US 201013395929 A
  • Priority: Sep 14, 2010
    US US 2010/0048829 W
  • Priority: Sep 21, 2009
    US US 24425009 P
  • Priority: Sep 14, 2009
    US US 24223809 P

Download Citation


Sign in to the Lens

Feedback